Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey

NCT ID: NCT04746443

Last Updated: 2021-02-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-08

Study Completion Date

2021-03-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to study the effects of Novel corona virus (COVID-19) on the psychological and mental health of college going students. Online version of the Event Impact Scale - Revised will be used to filled by the students who got afflicted by the novel corona virus (COVID-19).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Objective : To study the impact on psychological and mental health of COVID-19 affliction among college going students

Methodology:

Study Design: Cross-sectional Mode of implementation: Online surveys Population : COVID positive College students Inclusion criteria: Students positive to corona tests Exclusion criteria: students negative to corona tests

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

STUDENTS

COLLEGE STUDENTS WITH POSITIVE COVID-19 TEST

NOT APPLICABLE (NA)

Intervention Type OTHER

THE INTERVENTION GROUP IS NOT APPLICABLE TO THE CURRENT STUDY DESIGN

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NOT APPLICABLE (NA)

THE INTERVENTION GROUP IS NOT APPLICABLE TO THE CURRENT STUDY DESIGN

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Khalid University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Snehil Dixit

Dr. Snehil Dixit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

SNEHIL DIXIT, PhD

Role: PRINCIPAL_INVESTIGATOR

King Khalid University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

King Khalid University

Abhā, 'Asir Region, Saudi Arabia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

SNEHIL DIXIT, PHD

Role: CONTACT

+966559105324

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

SNEHIL DIXIT, PhD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECM#2020-2501

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.